Table 1.

The distribution of values of serologic type 1 and type 2 biomarkers

Biomarker% (n) Seropositive*MeanRange
Type 1 EBV antibody titers (n = 152)
    Anti-EBNA98.7 (150)1:2551:5-1:2,560
    Anti-VCA98.7 (150)1:8031:80-1:5,120
    Anti-EA-R3.2 (5)1:611:20-1:160
    Anti-EA-D10.5 (16)1:191:5-1:160
Type 2
    Total serum IgE, kilounits/L (n = 128)99.2 (127)390.0 ±   593.43.3-3,653.0
    sCD23, units/mL (n = 104)100.0 (104)52.5 ± 16.915.5-104.0
    sCD30, units/mL (n = 107)100.0 (107)47.1 ± 33.820.4-317.2
  • * Of all subjects tested for a given marker.

  • Geometric mean titer for EBV antibodies in seropositive subjects or arithmetic mean ± SD for type 2 markers among subjects with levels above assay detection limits.

  • Among marker seropositive subjects.